Search details
1.
Therapeutic Efficacy of 213Bi-labeled sdAbs in a Preclinical Model of Ovarian Cancer.
Mol Pharm
; 17(9): 3553-3566, 2020 09 08.
Article
in English
| MEDLINE | ID: mdl-32787284
2.
The anaphase-promoting complex/cyclosome: a new promising target in diffuse large B-cell lymphoma and mantle cell lymphoma.
Br J Cancer
; 120(12): 1137-1146, 2019 06.
Article
in English
| MEDLINE | ID: mdl-31089208
3.
DNMTi/HDACi combined epigenetic targeted treatment induces reprogramming of myeloma cells in the direction of normal plasma cells.
Br J Cancer
; 118(8): 1062-1073, 2018 04.
Article
in English
| MEDLINE | ID: mdl-29500406
4.
Tumour-associated macrophage-mediated survival of myeloma cells through STAT3 activation.
J Pathol
; 241(4): 534-546, 2017 03.
Article
in English
| MEDLINE | ID: mdl-27976373
5.
Metabolic Features of Multiple Myeloma.
Int J Mol Sci
; 19(4)2018 Apr 14.
Article
in English
| MEDLINE | ID: mdl-29662010
6.
Peripheral precocious puberty in Li-Fraumeni syndrome: a case report and literature review of pure androgen-secreting adrenocortical tumors.
J Med Case Rep
; 17(1): 195, 2023 May 14.
Article
in English
| MEDLINE | ID: mdl-37179382
7.
Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myeloma.
J Immunother Cancer
; 11(1)2023 01.
Article
in English
| MEDLINE | ID: mdl-36650020
8.
RNA-sequencing based first choice of treatment and determination of risk in multiple myeloma.
Front Immunol
; 14: 1286700, 2023.
Article
in English
| MEDLINE | ID: mdl-38035078
9.
Targeting S100A9 protein affects mTOR-ER stress signaling and increases venetoclax sensitivity in Acute Myeloid Leukemia.
Blood Cancer J
; 13(1): 188, 2023 12 18.
Article
in English
| MEDLINE | ID: mdl-38110349
10.
In anemia of multiple myeloma, hepcidin is induced by increased bone morphogenetic protein 2.
Blood
; 116(18): 3635-44, 2010 Nov 04.
Article
in English
| MEDLINE | ID: mdl-20679527
11.
Both mucosal-associated invariant and natural killer T-cell deficiency in multiple myeloma can be countered by PD-1 inhibition.
Haematologica
; 102(7): e266-e270, 2017 07.
Article
in English
| MEDLINE | ID: mdl-28385777
12.
Genetic profiling of human bone marrow mesenchymal stromal cells after in vitro expansion in clinical grade human platelet lysate.
Front Bioeng Biotechnol
; 10: 1008271, 2022.
Article
in English
| MEDLINE | ID: mdl-36324892
13.
The prognostic value and therapeutic targeting of myeloid-derived suppressor cells in hematological cancers.
Front Immunol
; 13: 1016059, 2022.
Article
in English
| MEDLINE | ID: mdl-36304465
14.
Inhibition of the Protein Arginine Methyltransferase PRMT5 in High-Risk Multiple Myeloma as a Novel Treatment Approach.
Front Cell Dev Biol
; 10: 879057, 2022.
Article
in English
| MEDLINE | ID: mdl-35757005
15.
Liquid Biopsy-Derived DNA Sources as Tools for Comprehensive Mutation Profiling in Multiple Myeloma: A Comparative Study.
Cancers (Basel)
; 14(19)2022 Oct 07.
Article
in English
| MEDLINE | ID: mdl-36230824
16.
Inhibiting Histone and DNA Methylation Improves Cancer Vaccination in an Experimental Model of Melanoma.
Front Immunol
; 13: 799636, 2022.
Article
in English
| MEDLINE | ID: mdl-35634329
17.
Epigenetic Modifiers: Anti-Neoplastic Drugs With Immunomodulating Potential.
Front Immunol
; 12: 652160, 2021.
Article
in English
| MEDLINE | ID: mdl-33859645
18.
G9a/GLP targeting in MM promotes autophagy-associated apoptosis and boosts proteasome inhibitor-mediated cell death.
Blood Adv
; 5(9): 2325-2338, 2021 05 11.
Article
in English
| MEDLINE | ID: mdl-33938943
19.
The Use of Murine Models for Studying Mechanistic Insights of Genomic Instability in Multiple Myeloma.
Front Genet
; 10: 740, 2019.
Article
in English
| MEDLINE | ID: mdl-31475039
20.
Maternal embryonic leucine zipper kinase is a novel target for diffuse large B cell lymphoma and mantle cell lymphoma.
Blood Cancer J
; 9(12): 87, 2019 11 18.
Article
in English
| MEDLINE | ID: mdl-31740676